Advertisement

Mushroom Consumption and Cardiovascular Health: A Systematic Review

Published:December 09, 2020DOI:https://doi.org/10.1016/j.amjmed.2020.10.035

      Abstract

      Introduction

      Edible mushrooms have a great nutritional value including high protein, essential amino acids, fiber, vitamins (B1, B2, B12, C, and D), minerals (calcium [Ca], potassium [K], magnesium [Mg], sodium [Na], phosphorus [P], copper [Cu], iron [Fe], manganese [Mn], and selenium [Se]), low fatty foods, and sodium. The objective of this systematic review was to determine the relationship between edible mushroom consumption and overall cardiovascular risk.

      Methods

      We systematically searched Ovid MEDLINE, Embase, Ovid Cochrane Database of Systematic Reviews, Scopus, and Web of Science from database inception from 1966 through August 2020 for observational studies that reported the association between edible mushroom consumption and cardiovascular risk. Two investigators independently reviewed data. Conflicts were resolved through consensus discussion.

      Results

      Of 1479 studies, we identified 7 prospective studies. Edible mushroom consumption may have favorable effects on lipid profiles by changing some metabolic markers such as low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, total cholesterol, and triglycerides. Moreover, edible mushroom consumption is probably associated with reduced mean blood pressure. The beneficial overall cardiovascular risk, stroke risk, and coronary artery disease of edible mushroom consumption are not consistent.

      Conclusions

      Edible mushroom consumption has not been shown to conclusively affect cardiovascular risk factors to date. However, potential health benefits may exist, including a favorable alteration of lipid profiles and blood pressure reduction.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. Lucier G, Allshouse JE, Lin B-H. Factors affecting US mushroom consumption. USDA Economic Research Service, VGS 295-01, March 2003. Available at: https://www.ers.usda.gov/webdocs/outlooks/39489/30836_vgs29501_002.pdf?v=4147.3. Accessed December 21, 2020.

        • Mattila P
        • Könkö K
        • Eurola M
        • et al.
        Contents of vitamins, mineral elements, and some phenolic compounds in cultivated mushrooms.
        J Agric Food Chem. 2001; 49: 2343-2348
        • Jose N
        • Ajith TA
        • Janardhanan KK
        Methanol extract of the oyster mushroom, Pleurotus florida, inhibits inflammation and platelet aggregation.
        Phytother Res. 2004; 18: 43-46
        • Bobek P
        • Galbavý S
        Hypocholesterolemic and antiatherogenic effect of oyster mushroom (Pleurotus ostreatus) in rabbits.
        Nahrung. 1999; 43: 339-342
        • Sarikurkcu C
        • Tepe B
        • Yamac M
        Evaluation of the antioxidant activity of four edible mushrooms from the Central Anatolia, Eskisehir - Turkey: Lactarius deterrimus, Suillus collitinus, Boletus edulis, Xerocomus chrysenteron.
        Bioresour Technol. 2008; 99: 6651-6655
        • Lee DH
        • Yang M
        • Giovannucci EL
        • Sun Q
        • Chavarro JE
        Mushroom consumption, biomarkers, and risk of cardiovascular disease and type 2 diabetes: a prospective cohort study of US women and men.
        Am J Clin Nutr. 2019; 110: 666-674
        • Pounis G
        • Costanzo S
        • Persichillo M
        • et al.
        Mushroom and dietary selenium intakes in relation to fasting glucose levels in a free-living Italian adult population: the Moli-sani Project.
        Diabetes Metab. 2014; 40: 34-42
      2. Gao Y, Chen G, Dai X, Ye J, Zhou S. A phase I/II study of Lingzhi mushroom Ganoderma lucidum (W. Curt.: Fr.) Lloyd (Aphyllophoromycetideae) extract in patients with coronary heart disease. Int J Med Mushrooms. 2004;6(4):33-40.

        • Klupp NL
        • Kiat H
        • Bensoussan A
        • Steiner GZ
        • Chang DH
        A double-blind, randomised, placebo-controlled trial of Ganoderma lucidum for the treatment of cardiovascular risk factors of metabolic syndrome.
        Sci Rep. 2016; 6: 29540
        • Chu TT
        • Benzie IF
        • Lam CW
        • Fok BS
        • Lee KK
        • Tomlinson B
        Study of potential cardioprotective effects of Ganoderma lucidum (Lingzhi): results of a controlled human intervention trial.
        Br J Nutr. 2012; 107: 1017-1027
        • Khatun K
        • Mahtab H
        • Khanam PA
        • Sayeed MA
        • Khan KA
        Oyster mushroom reduced blood glucose and cholesterol in diabetic subjects.
        Mymensingh Med J. 2007; 16: 94-99
        • Schneider I
        Lipid lowering effects of oyster mushroom (Pleurotus ostreatus) in humans.
        J Funct Food. 2011; 3: 17-24
        • Oyetayo OV
        Medicinal uses of mushrooms in Nigeria: towards full and sustainable exploitation.
        Afr J Tradit Complement Altern Med. 2011; 8: 267-274
        • Cheung PC
        Plasma and hepatic cholesterol levels and fecal neutral sterol excretion are altered in hamsters fed straw mushroom diets.
        J Nutr. 1998; 128: 1512-1516
        • Fukushima M
        • Nakano M
        • Morii Y
        • Ohashi T
        • Fujiwara Y
        • Sonoyama K
        Hepatic LDL receptor mRNA in rats is increased by dietary mushroom (Agaricus bisporus) fiber and sugar beet fiber.
        J Nutr. 2000; 130: 2151-2156
        • Bajaj M
        • Vadhera S
        • Brar AP
        • Soni GL
        Role of oyster mushroom (Pleurotus florida) as hypocholesterolemic/antiatherogenic agent.
        Indian J Exp Biol. 1997; 35: 1070-1075
        • Kała K
        • Kryczyk-Poprawa A
        • Rzewińska A
        • Muszyńska B
        Fruiting bodies of selected edible mushrooms as a potential source of lovastatin.
        Eur Food Res Technol. 2020; 246: 713-722
        • Kabir Y
        • Yamaguchi M
        • Kimura S
        Effect of shiitake (Lentinus edodes) and maitake (Grifola frondosa) mushrooms on blood pressure and plasma lipids of spontaneously hypertensive rats.
        J Nutr Sci Vitaminol (Tokyo). 1987; 33: 341-346
        • Kabir Y
        • Kimura S
        • Tamura T
        Dietary effect of Ganoderma lucidum mushroom on blood pressure and lipid levels in spontaneously hypertensive rats (SHR).
        J Nutr Sci Vitaminol (Tokyo). 1988; 34: 433-438
        • Miyazawa N
        • Okazaki M
        • Ohga S
        Antihypertensive effect of Pleurotus nebrodensis in spontaneously hypertensive rats.
        J Oleo Sci. 2008; 57: 675-681
        • Talpur NA
        • Echard BW
        • Fan AY
        • Jaffari O
        • Bagchi D
        • Preuss HG
        Antihypertensive and metabolic effects of whole Maitake mushroom powder and its fractions in two rat strains.
        Mol Cell Biochem. 2002; 237: 129-136